DEC 27, 2018 04:13 PM PST

Unapproved Stem Cell Treatments Sickened Over a Dozen People Last Year

WRITTEN BY: Carmen Leitch

The Centers for Disease Control and Prevention (CDC) found that at least a dozen people were sickened last year by unapproved stem cell treatments. Three of those patients were subjected to procedures with reagents made by Genetech, Inc. That company and others have been warned by the Food and Drug Administration (FDA) to correct the violations they have been notified about, and that failure to do so may result in “seizure or injunction.”

“The FDA is committed to advancing the field of cell-based regenerative medicine. We’re implementing new policies to make it more efficient to safely develop these promising new technologies. At the same time, we’re also focusing more resources on enforcement when we see companies skirt safety measures and put patients at risk. In this case, the company’s failure to put in place appropriate safeguards may have led to serious blood infections in patients,” said FDA Commissioner Scott Gottlieb, M.D. in a statement.

“We remain committed to supporting the development of safe and effective cell-based regenerative medicine and advancing our comprehensive regenerative medicine policy framework. These efforts include our work to encourage manufacturers to engage with the FDA early so that we can provide guidance about any applicable regulatory requirements. Even though a few sponsors have come to us, we are discouraged by the overall lack of manufacturers wanting to interact with the agency in this enforcement discretion period. The letters we’re issuing today to manufacturers, health care providers and clinics around the country are a reminder that there’s a clear line between appropriate development of these products and practices that sidestep important regulatory controls needed to protect patients. Time is running out for firms to come into compliance during our period of enforcement discretion. We’ll be increasing our oversight related to cell-based regenerative medicine as part of our comprehensive plan to promote beneficial innovation while protecting patients.”

Sources: CDC, FDA

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 05, 2019
Earth & The Environment
DEC 05, 2019
Greenland's Summer Melt Helps Scientists Track Sea Level Rise
This summer, the Greenland Ice Sheet experienced a significant melting event not seen since 2002, mainly due to the heatwave that swept through most of Eur...
DEC 05, 2019
Cardiology
DEC 05, 2019
Diagnosed With Atopic Dermatitis?
Eczema, dermatitis, atopic dermatitis: all names for the same disease of the skin. Although common in children during the first year of life, the condition...
DEC 05, 2019
Plants & Animals
DEC 05, 2019
Polar Bears Feast On Anything They Find, Even Rotting Whales
Polar bears are expert survivalists. Their noses are many times more powerful than a dog’s, and they can sniff out a potential meal from several mile...
DEC 05, 2019
Earth & The Environment
DEC 05, 2019
China to Create National Parks System
In one of the last remote regions of the world, the Chinese Government is pushing back against development and towards its version of the United States&rsq...
DEC 05, 2019
Chemistry & Physics
DEC 05, 2019
What are "Tears of Wine"?
Have you noticed: every time after pouring wine, near the top of a wine glass there's always a ring of liquid, where droplets form and continue to fall...
DEC 05, 2019
Space & Astronomy
DEC 05, 2019
Jupiter's Great Red Spot is as Powerful as it is Captivating
Jupiter is the largest known planet in our solar system, but even that isn’t the gas giant’s most discernible feature – that title belong...
Loading Comments...